به جمع مشترکان مگیران بپیوندید!

تنها با پرداخت 70 هزارتومان حق اشتراک سالانه به متن مقالات دسترسی داشته باشید و 100 مقاله را بدون هزینه دیگری دریافت کنید.

برای پرداخت حق اشتراک اگر عضو هستید وارد شوید در غیر این صورت حساب کاربری جدید ایجاد کنید

عضویت

مقالات رزومه بهاره زمانی

  • Bahareh Zamani, Amin Ramazani, Jamileh Saberzadeh, Puria Rostampour, Mohammad Ali Takhshid *
    Epithelial-to-mesenchymal transition (EMT) plays a critical role in colorectal cancer (CRC) metastasis. In the present study, we evaluated the effects of annexin A5 (ANXA5) overexpression on invasiveness as well as the expression of genes involved in EMT of HCT 116 cell line. PCMV6-AC-IRES-GFP plasmid harboring ANXA5 cDNA was constructed. HCT 116 cell line was transfected with recombinant plasmids using Lipofectamine 3000. Fluorescent microscopy was used to determine the efficiency of plasmid transfection. Cell viability was determined using the MTT assay. HCT 116 cell migration was evaluated using wound healing assay and transwell migration assay. Real-time quantitative polymerase chain reaction (RT-qPCR) was used to measure the expression of genes involved in EMT. The results of RT-qPCR showed overexpression of ANXA5 compared to the control group. ANXA5 overexpression had no significant effects on cell viability but significantly decreased the rate of wound closure in the wound healing assay as well as the number of migrated cells in transwell assay. Furthermore, ANXA5 overexpression decreased the expression of N-cadherin, Snail, Slug, MMP-2, and MMP-9 while the expression of E-cadherin increased following ANXA5 overexpression. However, VEGF expression did not significantly change after ANXA5 overexpression. Results of the present study suggest that ANXA5 overexpression might have inhibitory effects on the metastasis of CRC through modulating the expression of EMT- related genes.
    Keywords: Colorectal cancer, Epithelial to mesenchymal transition, Metastasis, ANXA5}
  • Mohammad Ali Takhshid *, Samaneh Davoudzadeh, Ghazal Noohi, Samaneh Naderi, Bahareh Zamani
    Background
    In this study, we aimed to investigate the combined effect of sodium valproate (SV) and lithium (Li) against viability, migration, and invasion of prostate cancer cell line.
    Method
    In this in vitro study, PC3 cells were treated with different concentrations of SV (2.5, 5.0, and 10 μM) and Li (2.5, 5.0, and 10 mM) either alone or in combination. Using the MTT test and annexin V/7ADD flow-cytometry, cell viability and apoptosis were assessed. Transwell chamber test was used to assess PC3 cells' invasion and migration.
    Results
    SV and Li alone had no significant effects on PC3 cell viability. However, the combination of SV and Li in all tested concentrations decreased the viability of PC3 cells in a dose dependent manner (P < 0.001). The combination of SV and Li (5.0 μM + 5.0 mM) increased apoptosis of PC3 cells compared with the control group (P = 0.003). Transwell assay showed that combination of SV with Li (5.0 μM + 5.0 mM) reduced the migration and invasion of PC3 cells significantly. The lack of a significant difference between the predicted and observed fractional inhibition for the effects of SV+Li suggests that SV and Li may have additive effects on lowering PC3 cell viability and invasiveness.
    Conclusion
    These findings show that combined low doses of SV and Li could decrease the viability and invasiveness of the PC3 cells; therefore, it can be considered as a new strategy for the treatment of prostate cancer. However, further in vivo studies are required to confirm the results of this study.
    Keywords: Prostatic Neoplasms, Valproic acid, Lithium, Combined modality therapy, apoptosis}
فهرست مطالب این نویسنده: 2 عنوان
  • بهاره زمانی
    زمانی، بهاره
    (1399) کارشناسی ارشد زیست فناوری پزشکی، دانشگاه علوم پزشکی شیراز
بدانید!
  • این فهرست شامل مطالبی از ایشان است که در سایت مگیران نمایه شده و توسط نویسنده تایید شده‌است.
  • مگیران تنها مقالات مجلات ایرانی عضو خود را نمایه می‌کند. بدیهی است مقالات منتشر شده نگارنده/پژوهشگر در مجلات خارجی، همایش‌ها و مجلاتی که با مگیران همکاری ندارند در این فهرست نیامده‌است.
  • اسامی نویسندگان همکار در صورت عضویت در مگیران و تایید مقالات نمایش داده می شود.
درخواست پشتیبانی - گزارش اشکال